Concepedia

Publication | Open Access

Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

1.3K

Citations

12

References

2009

Year

Abstract

Mepolizumab reduced the number of blood and sputum eosinophils and allowed prednisone sparing in patients who had asthma with sputum eosinophilia despite prednisone treatment. (ClinicalTrials.gov number, NCT00292877.)

References

YearCitations

Page 1